NCT05301790
Not yet recruiting
Not Applicable
Added Value of Breast MRI in Evaluation of Pathologic Response in Patients With Locally Advanced Breast Cancer Who Undergo Neoadjuvent Chemotherapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Role of MRI in Evaluation of Breast Cancer
- Sponsor
- Assiut University
- Enrollment
- 45
- Primary Endpoint
- comparison of MRI findings with pathologic results
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
evaluation of pathological response in breast mass by use of breast MRI in patients receiving neoadjuvent chemotherapy via comparison with pathological results
Detailed Description
evaluation of pathological response in locally advanced breast masses by use of breast MRI in patients receiving neoadjuvent chemotherapy via comparison with pathological results
Investigators
Doaa Maher Ebied Maher
resident
Assiut University
Eligibility Criteria
Inclusion Criteria
- •all women referred to the radiology department for breast MRI examination either for screening, evaluation of suspicious lesions onsono-mammography \\
- •Patients with locally advanced breast cancer
- •Patients with early stage breast cancer and chemo-responsive tumour markers (i.e. triple negative, Her2+), who will benefit from downsizing for breast conserving surgery (BCS)
- •Absolute or Relative contraindications to surgery (advanced age/multiple medical comorbidities) in the setting of estrogen receptor positive tumours (for consideration of neoadjuvant endocrine therapy)3
- •Patients must be elder than 18 years old.
- •patients with accepted renal function
Exclusion Criteria
- •Patients with metastatic breast cancer.
- •Patient with breast mass more than 5 cm .
- •Patients with fungating breast mass .
- •Patients with stage IV \[tumor spread to chest wall and to skin \].
- •pregnant women especially in 1th trimester.
- •Patient with presence of any paramagnetic substance as pacemakers.
- •severely ill patients .
- •patients with claustrophobia.
- •arrhythmic patients
Outcomes
Primary Outcomes
comparison of MRI findings with pathologic results
Time Frame: baseline
added value of breast MRI in evaluation of pathologic response in patients with locally advanced breast cancer who undergo neoadjvent chemotherapy
Similar Trials
Terminated
Not Applicable
Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy RatesEarly Stage Breast CancerNCT01166581Summa Health System300
Completed
Phase 2
Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast CancerBreast CancerNCT00043017American College of Radiology Imaging Network356
Active, not recruiting
Not Applicable
MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) StudyBreast CancerNCT02301767Memorial Sloan Kettering Cancer Center2,187
Unknown
Not Applicable
Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast CancerBreast CancerNCT03580837University Hospital, Strasbourg, France100
Active, not recruiting
Not Applicable
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer PatientsHealthy SubjectNCT03303846City of Hope Medical Center344